AI
Friday, June 05, 2015 3:11:02 PM
>> more fringe companies
There is a perfect candidate falling into that category. I don't think I need to name it
Here are what I am following divided into 3 categories, not necessarily oncology companies.
CAR-T/TCR/TIL: ADAP, BLCM, BLUE, CBMG, CLLS, JUNO, KITE, LBIO, ZIOP.
Bi-specific that directly engaging T-cell or NK-cell: AFMD, MGNX, XNCR.
Checkpoint and others: ABLX, ADRO, ADXS, AGEN, ATRA, CGEN, CLDX, DVAX, FPRX, GEN, IMDZ, INCY, IPH, MOR, NKTR, NLNK, SGEN, SRNE, TRIL, TSRO; ALNY, TKMR.
There is a perfect candidate falling into that category. I don't think I need to name it
Here are what I am following divided into 3 categories, not necessarily oncology companies.
CAR-T/TCR/TIL: ADAP, BLCM, BLUE, CBMG, CLLS, JUNO, KITE, LBIO, ZIOP.
Bi-specific that directly engaging T-cell or NK-cell: AFMD, MGNX, XNCR.
Checkpoint and others: ABLX, ADRO, ADXS, AGEN, ATRA, CGEN, CLDX, DVAX, FPRX, GEN, IMDZ, INCY, IPH, MOR, NKTR, NLNK, SGEN, SRNE, TRIL, TSRO; ALNY, TKMR.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
